Stem cell therapy is one of the most promising therapeutic innovations to help restore
cardiac structure and function after ischemic insults to the heart. However, phase I and II …

Myocardial infarction leads to loss of cardiomyocytes, scar formation, ventricular remodeling
and eventually deterioration of heart function. Over the past decade, stem cell therapy has …

Cell‐based therapy is a promising approach for cardiac repair in patients with coronary
artery disease. In preclinical and early clinical studies, investigators have preliminary …

The prognosis of patients with myocardial infarction (MI) and resultant chronic heart failure
remains extremely poor despite continuous advancements in optimal medical therapy and …

and expanded in culture to be used for myocardial repair. 5 Application of CSC in
experimental acute MI reduced LV remodeling, improved contractility and reduced the infarct …

Acute myocardial infarction (AMI) is one of the most significant causes of morbidity and
mortality worldwide. Stem cells represent an enormous chance to rebuild damaged heart …

Restoration of cardiovascular function is the ultimate goal of stem-cell-based therapy. In
principle, cardiovascular stem cells can improve cardiac function via de novo …

Stem cells possessing the potential to replace damaged myocardium with functional
myocytes have drawn increasing attention in the past decade in treating ischemic heart …

Myocardial infarction results in loss of cardiomyocytes, scar formation, ventricular
remodelling, and eventually heart failure. In recent years, cell therapy has emerged as a …

Various stem cell types have been tested for regenerating damaged myocardium after
myocardial infarction. However, the results of clinical trials have not been consistent, with …